BNP PARIBAS FINANCIAL MARKETS - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 34 filers reported holding UNITED THERAPEUTICS CORP DEL in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q2 2014$3,012,960,000,000
+4031.7%
16,000,000
+3074.6%
2.83%
+5348.1%
Q2 2013$72,922,800,000504,0000.05%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q2 2013
NameSharesValueWeighting ↓
CAMDEN ASSET MANAGEMENT L P /CA 41,257,000$77,692,0004.50%
Castle Creek Arbitrage, LLC 31,200,000$58,823,0003.72%
Ferox Capital Management LP 3,000,000$5,637,0003.17%
GRACE BROTHERS MANAGEMENT LLC 1,750,000$3,300,0002.90%
BNP PARIBAS FINANCIAL MARKETS 16,000,000$3,012,960,000,0002.83%
BASSO CAPITAL MANAGEMENT, L.P. 8,725,000$16,452,0002.74%
WHITEBOX ADVISORS LLC 21,854,000$41,154,0001.62%
WOLVERINE ASSET MANAGEMENT LLC 39,250,000$74,033,0001.62%
QVT Financial LP 10,000,000$18,883,0001.02%
CSS LLC/IL 7,250,000$13,670,0000.57%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders